Product Information
ZAFIRLUKAST 10 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.5169 per EA under NDC 59651029160. Its NADAC has been published 117 times since Jul 10, 2024.
FDA first approved this application on Nov 27, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651029160
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ZAFIRLUKASTApproval Type
Generic (ANDA)
FDA Application
ANDA213163FDA Approved
11/27/2023
TE Code
AB
On Market Since
11/27/2023
Pharmacological Classes
Price Statistics
The NADAC for ZAFIRLUKAST 10 MG TABLET has been published 117 times since Jul 10, 2024, and over the history we have for it it has declined 16.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5169 per EA |
|---|---|
| All-time high | $0.7093 (Oct 16, 2024) |
| All-time low | $0.4056 (Feb 19, 2025) |
| 52-week high | $0.6132 |
| 52-week low | $0.5023 |
| Median price | $0.5295 |
| Average price | $0.5559 |
| Largest weekly change | -23.1% (Nov 20, 2024) |
| Weeks tracked | 117 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zafirlukast market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Leukotriene Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZAFIRLUKAST 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZAFIRLUKAST 10 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.5169 per EA (NDC 59651029160), effective Sep 30, 2026.
How has the price of ZAFIRLUKAST 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZAFIRLUKAST 10 MG TABLET has declined 16.1%. It has been tracked across 117 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for ZAFIRLUKAST 10 MG TABLET?
Since Jul 10, 2024, the NADAC for ZAFIRLUKAST 10 MG TABLET has ranged from a low of $0.4056 (Feb 19, 2025) to a high of $0.7093 (Oct 16, 2024), with a median of $0.5295 per EA.
Are there cheaper alternatives to ZAFIRLUKAST 10 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZAFIRLUKAST 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ZAFIRLUKAST 10 MG TABLET?
ZAFIRLUKAST 10 MG TABLET (NDC 59651029160) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.